Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study

Vanessa D. de Mello, Jussi Paananen, Jaana Lindström, Maria Lankinen, Lin Shi, Johanna Kuusisto, Jussi Pihlajamäki, Seppo Auriola, Marko Lehtonen, Olov Rolandsson, Ingvar A. Bergdahl, Elise Nordin, Pirjo Ilanne‐Parikka, Sirkka Keinänen‐Kiukaanniemi, Rikard Landberg, Johan G. Eriksson, Jaakko Tuomilehto, Kati Hanhineva, Matti Uusitupa

Scientific Reports, 2017

University of Eastern Finland, Finnish Institute for Health and Welfare, Swedish University of Agricultural Sciences, Kuopio University Hospital, Biocenter Finland, Umeå University, Tampere University Hospital, Finnish Diabetes Association, Tampere University, Oulu University Hospital, University of Oulu, Karolinska Institutet, Vaasa Central Hospital, University of Helsinki, Helsinki University Hospital, Folkhälsans Forskningscentrum, King Abdulaziz University, Universität für Weiterbildung Krems

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with Scientific Reports. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

371

Citations

View on Google Scholar

Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study

Abstract

Journal Details

Join JournalsHub

Welcome Back